|
Abstract:
|
Bigger is Better in Samsung's Approach to Biomanufacturing, 3p. |
|
Abstract:
|
CMO Roundup: Expansions for Biomanufacturing, 2p. |
|
Abstract:
|
Designing a Single-Use Biopharmaceutical Process, 2p. |
|
Abstract:
|
FDA is Not Playing Games with Biosimilars, 1p. |
|
Abstract:
|
FDA Seeks to Revive Quality Metrics Initiative, 2p. |
|
Abstract:
|
Lifecycle-Based Process Validation Emphasizes the Need for Continued Process Verification, 4p. |
|
Abstract:
|
Multi-Purpose Biopharmaceutical Manufacturing Facilities, 5p. |
|
Abstract:
|
USP’s Update to Compounding Rules Could Affect Cleanroom Design |
|
Abstract:
|
What Ifs in the Five-Year Plan, 2p. |
|
Article:
|
Aseptic Production, Gowning Systems and Airborne Contaminants |
|
Article:
|
Assuring the Safe Handling of Potent APIs, Intermediates, and Solid-Dosage Drugs |
|
Article:
|
Best Practices for Design and Operation of Multiproduct Manufacturing Facilities |
|
Article:
|
Best Practices for Design and Operation of Multiproduct Manufacturing Facilities |
|
Article:
|
Best Practices in Using Isolator Technology |
|
Article:
|
Best Practices in Using Isolator Technology |
|
Article:
|
Bioprocessing Facilities and FDA Inspection Problems |
|
Article:
|
Choosing a Cleanroom Infrastructure Technology |
|
Article:
|
Cleanroom Cleaning: Proper Methodology and Determining Efficacy by Ryan Burke, and Madison Prifti |
|
Article:
|
CMOs Leading the Way on Single-Use Systems Adoption |
|
Article:
|
Continuous Manufacturing Gains Major Push from FDA |
|
Article:
|
Electrodeionization in Pharmaceutical Water Treatment |
|
Article:
|
Embracing the Digital Factory for Bio/Pharma Manufacturing |
|
Article:
|
FDA Advances New Approach to Drug Quality Assessment |
|
Article:
|
Getting to the Root of Quality Problems |
|
Article:
|
GMPs Guide COVID-19 Vaccine Manufacturing |
|
Article:
|
HPAPI Capacity Challenges, 4p. |
|
Article:
|
Human-Centered Work: How Pharma Can Move to a Blame-Free Culture |
|
Article:
|
Improving Efficiency for Sustainable Pharmaceutical Facilities |
|
Article:
|
Inhalation Drug Delivery: the Impact of Particle Size Reduction, 4p. |
|
Article:
|
Inside Italy’s Pharmaceutical Industry
by Abi Millar |
|
Article:
|
Integrating Industrial Internet of Things (IoT)and Pharmaceutical Manufacturing Processes |
|
Article:
|
Intelligent Packaging Promotes Interaction with Patients |
|
Article:
|
Navigating Uncharted Waters. Data and science must guide FDA in making pressure-filled COVID-19 vaccine and therapy approval decisions. |
|
Article:
|
Not a Particle of Doubt |
|
Article:
|
Overcoming Operational and Regulatory Challenges in Autologous Cell-Therapy Facilities |
|
Article:
|
Pandemic Spurs Efforts to Boost Pharma Manufacturing in US |
|
Article:
|
Performing Remote Audits During the Pandemic |
|
Article:
|
Pharma Contract Market Update, 3p. |
|
Article:
|
Pharma Facilities Still Have a Lot to Learn |
|
Article:
|
Qualification of a Swab Sampling Procedure for Cleaning Validation |
|
Article:
|
Real-World Vapor Phase Hydrogen Peroxide Decontamination |
|
Article:
|
Resuming Operations During a Pandemic |
|
Article:
|
Risk-Averse Fill/Finish Industry Embraces Change, 4p. |
|
Article:
|
Robotics Solve Aseptic Filling Challenges, 3p. |
|
Article:
|
Understanding the Critical Role of Integrity Testing in Laboratory Sterility Filtration |
|
Article:
|
Understanding the Impact of Annex 1 on Isolator Design |